CVE-2023-53734

Dec. 4, 2025, 9:16 p.m.

8.7
High

Description

dawa-pharma-1.0 allows unauthenticated attackers to execute SQL queries on the server, allowing them to access sensitive information and potentially gain administrative access.

Product(s) Impacted

Vendor Product Versions
Dawa-pharma
  • Dawa-pharma
  • *

Weaknesses

Common security weaknesses mapped to this vulnerability.

CWE-89
Improper Neutralization of Special Elements used in an SQL Command ('SQL Injection')
The product constructs all or part of an SQL command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended SQL command when it is sent to a downstream component.

CVSS Score

8.7 / 10

CVSS Data - 4.0

  • Attack Vector: NETWORK
  • Attack Complexity: LOW
  • Attack Requirements: NONE
  • Privileges Required: NONE
  • User Interaction: NONE
  • Scope:
  • Confidentiality Impact: HIGH
  • Integrity Impact: NONE
  • Availability Impact: NONE
  • Exploit Maturity: NOT_DEFINED
  • CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

    View Vector String

Timeline

Published: Dec. 4, 2025, 9:16 p.m.
Last Modified: Dec. 4, 2025, 9:16 p.m.

Status : Received

CVE has been recently published to the CVE List and has been received by the NVD.

More info

Source

disclosure@vulncheck.com

*Disclaimer: Some vulnerabilities do not have an associated CPE. To enhance the data, we use AI to infer CPEs based on CVE details. This is an automated process and might not always be accurate.